“And nobody else has access?”
“Only me.”
Nadia folded her arms. “Tell him everything.”
I looked toward the windows.
Snow drifted between the towers outside, softening the city into silence.
“My algorithm was never the real asset,” I said.
Rourke waited.
“The board thought Ardent Helix’s value came from early cancer detection. That’s what Harrison thought too. But during development, I found something else.”
“What?”
“A way to identify synthetic alterations in blood-cell DNA.”
Rourke leaned forward.
“Gene editing?”
“Not exactly. The system can distinguish naturally occurring mutations from artificially induced ones. It can identify whether someone has been exposed to certain engineered viral vectors or experimental treatments—even years later.”
Nadia had heard the explanation before, but her face remained tense.
Rourke glanced toward the case.
“Why is that worth millions?”
“Because several pharmaceutical companies have conducted unauthorized human trials overseas. Some used vulnerable populations. Refugees. Prisoners. Children in unregulated clinics.”
Silence filled the room.
My voice grew quieter.
“Ardent’s system can prove it.”
Rourke’s expression changed.
“And Voss Meridian knew?”
“I thought they didn’t. Then I discovered Harrison was transferring patents and deleting research logs. At first, I believed he wanted the commercial rights. But the transfers led to Northline Genomics.”
Rourke opened a file.
“A company controlled through a trust in Luxembourg.”
“Yes.”
“Who controls the trust?”
“I don’t know.”
He slid a photograph across the table.
It showed Harrison leaving a hotel in Zurich with an older man in a charcoal overcoat.
“Do you recognize him?”
“No.”
“Dr. Emil Soren. Former director of the Halcyon Pediatric Research Initiative.”
The name struck me like cold water.
Halcyon had been shut down after allegations of illegal genetic trials in Eastern Europe. No charges were ever filed because patient records disappeared.
Rourke tapped the black case.
“We believe Mr. Soren has spent six years trying to locate evidence that survived.”
My fingers tightened around the edge of the table.
“Harrison married me seven years ago.”
“Yes.”
The room seemed to tilt.
I looked at Nadia.
She was staring at Rourke, equally stunned.
“What are you saying?” I whispered.
Rourke’s voice was careful.
“We believe Harrison’s relationship with you may have begun as an assignment.”
No betrayal had ever prepared me for those words.
The affair. The forged signatures. The threats. The years of being diminished inside my own marriage.
Those wounds suddenly looked smaller beside the possibility that **my entire love story had been manufactured.**
I remembered Harrison at the conference in Chicago, appearing beside me after my presentation.
I remembered how perfectly he understood my research.
I remembered his first words.
*You’re going to change medicine.*
He had known exactly what I was building.
“He didn’t marry me for my company,” I said.
Rourke’s eyes remained on mine.
“He may have married you for what your company could uncover.”
I stood abruptly and walked toward the windows.
My reflection stared back at me: pale face, shaking hands, a woman trying to decide whether seven years of memories had contained a single honest moment.
Nadia came beside me.
“Claire.”
“I loved him.”
“I know.”
“No. I don’t think you understand. I loved him before the company had value. Before the patents. Before any of this.”
Behind us, Rourke closed the file.
“There’s something else.”
I turned.
“We reviewed the records you provided. Several transfers were authorized using a biometric token issued to you.”
“That’s impossible.”
“Where did you keep it?”
“In a safe at home.”
“Who knew the code?”
“Only—”
The answer died in my throat.
Harrison.
He had installed the safe as an anniversary gift.
A ridiculous gift, I had thought, laughing as he showed me the fingerprint lock.
“For everything worth protecting,” he had said.
Rourke placed another document on the table.
A transfer dated three years earlier.
The day I miscarried.
While I had been sedated in a hospital, Harrison had used my fingerprint to authorize the first patent transfer.
**He had held my unconscious hand against a biometric scanner while our child was dying inside me.**
I sat down because my legs could no longer support me.
Nadia covered her mouth.
Rourke said something, but I could not hear him.
All I could see was Harrison beside my hospital bed, brushing hair from my forehead.
He had cried that night.
Or pretended to.
“I’m sorry,” Rourke said.
My grief hardened into something clean and sharp.
“Don’t be.”
I lifted my eyes.
“Tell me how we bury him.”
—
Harrison was arrested that afternoon.
Not for espionage. Not yet.
The federal investigation was too large, too delicate, and too incomplete.
They arrested him for wire fraud, identity theft, obstruction, and attempted unlawful entry. Patricia screamed at reporters outside the building while cameras recorded every second.
“This is persecution!” she shouted. “My son is a respected businessman!”
Then a journalist asked whether she had spent more than eight hundred thousand dollars on a card belonging to her former daughter-in-law.
Patricia stopped speaking.
By evening, the story was everywhere.
**Voss Meridian’s stock fell thirty-two percent before markets closed.**
Board members resigned. Banks froze accounts. Simone Vale vanished from her apartment before federal agents arrived.
But Harrison posted bail before midnight.
At 1:12 a.m., he called from an unknown number.
I answered.
“You have no idea what you’ve done,” he said.
His voice sounded different without confidence holding it together.
“You keep saying that.”
“You think the FBI can protect you?”
“Is that a threat?”
“It’s a warning.”
“From you?”
“From the people who own Voss Meridian.”
“I thought your family owned it.”
He laughed once, bitterly.
“My family has never owned anything.”
The words landed heavily.
“Who does?”
“I can tell you.”
“Then tell the FBI.”
“I can’t.”
“Why?”
“Because they have my sister.”
I frowned.
“Harrison, you don’t have a sister.”
“That’s what Mother told you.”
There was panic in his breathing now.
“Her name is Elise. She was born two years before me. When she was twelve, she developed leukemia. Halcyon offered an experimental treatment. It saved her life, but it changed her.”
Popular Posts
→- 1
- 2
- 3
- 4
Recently Viewed
Stories you read recently will appear here.
